dapi has been researched along with Demyelinating Diseases in 8 studies
DAPI: RN given refers to parent cpd.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, relapsing-remitting experimental autoimmune encephalomyelitis was induced through active immunization of SJL/J mice with a myelin proteolipid protein peptide." | 1.40 | Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. ( Cusick, MF; Fujinami, RS; Libbey, JE; Song, SK; Sun, P; Trinkaus, K; Wang, X; Wang, Y, 2014) |
| "During acute demyelination, microglial/macrophage activation was most extensive and axons exhibited swellings, neurofilament dephosphorylation, and reduced diameters." | 1.36 | Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. ( Armstrong, RC; Budde, MD; Chen, CI; Cross, AH; McDaniel, DP; Song, SK; Tobin, JE; Trinkaus, K; Xie, M, 2010) |
| "Using a gliotoxin model of demyelination we were therefore able to ascertain the in vivo effect of rhGGF-2 following local CNS delivery in a model that is not confounded by the concurrent presence of an immune-mediated process." | 1.32 | Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS. ( Dunning, MD; Franklin, RJ; Lakatos, A; Li, WW; Marchionni, M; Penderis, J; Woodruff, RH; Zhao, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Cusick, MF | 1 |
| Wang, Y | 1 |
| Sun, P | 1 |
| Libbey, JE | 1 |
| Trinkaus, K | 2 |
| Fujinami, RS | 1 |
| Song, SK | 2 |
| Marques, SA | 1 |
| Garcez, VF | 1 |
| Del Bel, EA | 1 |
| Martinez, AM | 1 |
| Yun, B | 1 |
| Anderegg, A | 1 |
| Menichella, D | 1 |
| Wrabetz, L | 1 |
| Feltri, ML | 1 |
| Awatramani, R | 1 |
| Xie, M | 1 |
| Tobin, JE | 1 |
| Budde, MD | 1 |
| Chen, CI | 1 |
| Cross, AH | 1 |
| McDaniel, DP | 1 |
| Armstrong, RC | 1 |
| Brundin, L | 1 |
| Brismar, H | 1 |
| Danilov, AI | 1 |
| Olsson, T | 1 |
| Johansson, CB | 1 |
| Penderis, J | 1 |
| Woodruff, RH | 1 |
| Lakatos, A | 1 |
| Li, WW | 1 |
| Dunning, MD | 1 |
| Zhao, C | 1 |
| Marchionni, M | 1 |
| Franklin, RJ | 1 |
| Adamo, AM | 1 |
| Paez, PM | 1 |
| Escobar Cabrera, OE | 1 |
| Wolfson, M | 1 |
| Franco, PG | 1 |
| Pasquini, JM | 1 |
| Soto, EF | 1 |
| Marriott, MP | 1 |
| Emery, B | 1 |
| Cate, HS | 1 |
| Binder, MD | 1 |
| Kemper, D | 1 |
| Wu, Q | 1 |
| Kolbe, S | 1 |
| Gordon, IR | 1 |
| Wang, H | 1 |
| Egan, G | 1 |
| Murray, S | 1 |
| Butzkueven, H | 1 |
| Kilpatrick, TJ | 1 |
8 other studies available for dapi and Demyelinating Diseases
| Article | Year |
|---|---|
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Topics: Animals; Axons; Biomarkers; Demyelinating Diseases; Diffusion Tensor Imaging; Encephalomyelitis, Aut | 2014 |
A simple, inexpensive and easily reproducible model of spinal cord injury in mice: morphological and functional assessment.
Topics: Animals; Cell Death; Demyelinating Diseases; Disease Models, Animal; Exploratory Behavior; Female; G | 2009 |
MicroRNA-deficient Schwann cells display congenital hypomyelination.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Cell Differentiation; Cyclin D1; DEAD-box RNA Helicase | 2010 |
Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.
Topics: Animals; CD11b Antigen; Corpus Callosum; Cuprizone; Demyelinating Diseases; Diffuse Axonal Injury; D | 2010 |
Neural stem cells: a potential source for remyelination in neuroinflammatory disease.
Topics: Animals; Bromodeoxyuridine; Carbocyanines; Cell Count; Demyelinating Diseases; Disease Models, Anima | 2003 |
Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cells, Cultured; Central Nervous System; Demy | 2003 |
Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antigens; Apoproteins; Brain; Bromodeoxyuridine; CD | 2006 |
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Topics: Analysis of Variance; Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Gl | 2008 |